About 1 in 8 people with autoimmune diseases who start the two-dose shingles vaccine series do not complete it, mostly because they worry about having side effects after the first shot.

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.